Overweight
📧 Sign up to get email alerts when something new happens for Overweight.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes [EARLY_Phase 1]
A first-in-human Phase 1 study of HCR-188 in overweight or obese adults without type 2 diabetes has been suspended.
-
CLINICAL_TRIALS other · 2025-11-26Clinical Trial Update: Dietary Guidelines for Americans-Ultra Processed Study [NA]
Clinical trial update indicates the USDA's ultra-processed foods study under the Dietary Guidelines for Americans is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects [Phase 3]
Phase III trial to evaluate the efficacy and safety of GZR18 Injection in adults who are obese or overweight; the study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Community Outreach - Obesity Prevention Trial (CO-OPT) [NA]
Update on a completed obesity prevention clinical trial (CO-OPT) focusing on community outreach to address obesity and overweight in childre…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Mothers' Thoughts About Kids and Eating [NA]
Completed clinical trial update from NHGRI examining mothers' thoughts about their children’s eating in the context of overweight conditions…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Effects of Protein Supplementation on 4 Weeks of Alternate-day Fasting on Fasting Blood Glucose, Resting Blood Pressure, and Body Composition in Young Men [NA]
A completed trial from Nanyang Technological University examined whether protein supplementation during four weeks of alternate-day fasting …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention [NA]
Clinical trial update for the FaibaGo Study at the University of Bern, investigating long-term weight reduction via a low-threshold interven…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Impact of Education During Pregnancy in Overweight Pregnant Women [NA]
A completed clinical trial evaluating the impact of education during pregnancy on overweight pregnant women.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: The Impact of Stationary Combined Exercise on Adiponectin and Hs-CRP Levels in Overweight Women [NA]
This completed clinical trial examines the impact of stationary combined exercise on adiponectin and high-sensitivity C-reactive protein (hs…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight [Phase 1]
Phase 1 study of Eloralintide (LY3841136) in Chinese participants with obesity or overweight completed; the trial aimed to assess safety, to…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin [Phase 2]
A Phase 2 study evaluating subcutaneous NNC0487-0111 in adults with overweight or obesity has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects [NA]
This clinical trial evaluated Akkermansia muciniphila Akk11 for metabolic and gut health in adults who are overweight or obese; the study ha…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects [Phase 2]
Phase 2 clinical trial of IBI362 for weight loss in overweight and obese Chinese adults has completed.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection [Phase 1]
Phase I study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-5817 injection in obesity/overweight; currently…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
This clinical trial update describes the GLOBE patient registry for overweight and obesity, focusing on developing and implementing disease-…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Online Family Dyadic Skills Training for Black Adults in Behavioral Weight Loss Program [NA]
The clinical trial examining online family dyadic skills training within a behavioral weight loss program for Black adults has completed and…
-
FDA approval · 2025-11-05FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
FDA approved a supplemental application for CONTRAVE EXTENDED-RELEASE (naltrexone hydrochloride and bupropion hydrochloride) by Nalpropion P…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities [Phase 3]
Phase 3 trial evaluating orforglipron (LY3502970) in adults with obesity or overweight with weight-related comorbidities is currently active…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity [NA]
This ClinicalTrials.gov update reports the completion of a study evaluating produce prescription programs for adults with overweight or obes…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: TOTAL: A Multisite RCT [NA]
A multisite clinical trial update for TOTAL: A Multisite RCT evaluating obesity and overweight conditions. The study is currently active but…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
This completed trial compares tirzepatide and semaglutide for cardiovascular risk in adults with type 2 diabetes and overweight. The study p…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Study of LY3841136 in Overweight and Obese Participants [Phase 1]
Phase 1 study of LY3841136 in overweight and obese participants has completed.
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers [NA]
This clinical trial update notes NYU's NYUCI-ES study evaluating a psychosocial intervention to improve health outcomes for Chinese and Kore…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Tirzepatide for Alcohol Use Disorder [Phase 2]
Phase 2 clinical trial update for tirzepatide (Mounjaro) in alcohol use disorder, with recruitment ongoing and exploration of obesity/overwe…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity [Phase 1]
A Phase 1 study evaluating subcutaneous AMG 133 in adults with overweight or obesity has completed enrollment/status.